Global In Vitro Diagnostic Market Analysis

The IVD services have greatly contributed to the global diagnostic industry during the past few years. The IVD market has been growing at the stupendous rate worldwide mainly on the back of factors, such as technological advancements, significant developments in diagnostic services, and active private sector participation. Other factors, such as increasing disease prevalence and high disposable income have also contributed to the development of IVD services industry, which was estimated to have reached US$ 44 Billion in 2010.

According to our new research report “Global In Vitro Diagnostic Market Analysis”, the global IVD services industry is likely to grow at a CAGR of around 5% during 2011-2013 to reach around US$ 52 Billion by 2013 end. Innovation in technology is expected to play a vital role in future also and in this regard, we have done an extensive research and analysis of all the segments of IVD services industry.

Among the key constituents of the global IVD market, point-of-care segment has the largest part followed by immunochemistry and molecular diagnostics. As healthcare spending is increasing across the globe, these segments are likely to witness robust growth in their revenue patterns. Tests for diseases, such as diabetes, cardiovascular, and cancer are providing strong support to the industry developments. Moreover, the influenza diagnostic services are expected to provide momentum to the global IVD industry during the forecast period (2011-2013).

Our report covers almost every important aspect of the global IVD market and contains reliable statistical data and brief overview of the traditional IVD testing markets and new emerging technological products. The report also provides a detail and effective analysis of the current trends in the regional IVD markets across the globe to comprehend the market dynamics. Besides, the report contains analysis of market size, growth, share, segmentation, and geographic distribution to facilitate clients understand opportunities and challenges before making any investment decision.

The report has carefully examined the IVD market in terms of industrial developments, competitive landscape, and regional basis to identify the potential growth segments. Under regional segmentation, the IVD market is classified into North America, Europe, and other key countries.
[Fade out the market survey infos]

1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Market Drivers
4.1 Chronic and Infectious Diseases
4.2 New Technologies
4.3 Emerging Markets
4.4 Diversifying Applications
4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2013
5.1 Point-of-Care Diagnostics
5.2 Clinical Chemistry and Immunochemistry
5.3 Molecular Diagnostics
5.4 Microbiology
5.5 Homeostasis
5.6 Hematology
5.7 Immunohematology
6. Segmentation by Indication (Current and Future Scenario - 2013)
6.1 Diabetes
6.2 Cardiovascular
6.3 Cancer
6.4 HIV
6.5 Tuberculosis
6.6 Influenza
7. Geographical Segmentation (Current and Future Scenario - 2013)
7.1 North America
7.1.1 United States
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 United Kingdom
7.2.5 Spain
7.2.6 Other European Countries
7.3 Japan
7.4 Other Key Countries
7.4.1 China
7.4.2 India
7.4.3 Turkey
7.4.4 Brazil
7.4.5 Mexico
8. Consumer Behavior Analysis
9. Emerging Sectors
9.1 Companion Diagnostics/Theranostics
9.2 Nanodiagnostics
10. Recent Developments and M&As
11. Industry Restraints
11.1 Regulatory and Reimbursement Issues
11.2 R&D and Short Product Lifecycle
11.3 Cost Control
12. Competitive Landscape
12.1 Market Share of Top Players
12.2 Key Players
12.2.1 Roche Holding Ltd.
12.2.2 Abbott Laboratories
12.2.3 Siemens AG
12.2.4 Beckman Coulter
12.2.5 Ortho-Clinical Diagnostics
[Fade out table of contents]

Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests
Table 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2010
Table 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
Table 5-3: Global - Share of Top Players in Clinical Chemistry and Immunochemistry Market (2009)
Table 5-4: Global - Share of Top Players in Molecular Diagnostic Market (2009)
Table 5-5: Global - Share of Top Players in Microbiology Diagnostic Market (2009)
Table 5-6: Global - Share of Top Players in Homeostasis Diagnostic Market (2009)
Table 6-1: Global - Leading Companies in Diabetes Equipment Sales (Billion US$)
Table 7-1: Other European Countries - In Vitro Diagnostic Market (Million Euro), 2009
Table 12-1: Roche Holding Ltd. - Strengths & Weaknesses
Table 12-2: Abbott Laboratories - Strengths & Weaknesses
Table 12-3: Siemens AG - Strengths & Weaknesses
Table 12-4: Beckman Coulter - Strengths & Weaknesses
Table 12-5: Ortho-Clinical Diagnostics - Strengths & Weaknesses
Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008-2013
Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2010
Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-3: Global - Point of Care Diagnostic Market (Billion US$), 2009 & 2010
Figure 5-4: Global - Point of Care Diagnostic Market by Segment (%)
Figure 5-5: Global - Point of Care Diagnostic Market by Distribution (%), 2007
Figure 5-6: Global - Forecast for Point of Care Diagnostic Market (Billion US$), 2011-2013
Figure 5-7: Global - Clinical Chemistry and Immunochemistry Market (Billion US$), 2009 & 2010
Figure 5-8: Global - Forecast for Clinical Chemistry & Immunochemistry Market (Billion US$), 2011-2013
Figure 5-9: Global - Molecular Diagnostic Market (Billion US$), 2009 & 2010
Figure 5-10: Global - Forecast for Molecular Diagnostic Market (Billion US$), 2011-2013
Figure 5-11: Global - Microbiology Diagnostic Market (Billion US$), 2009 & 2010
Figure 5-12: Global - Forecast for Microbiology Diagnostic Market (Billion US$), 2011-2013
Figure 5-13: Global - Homeostasis Diagnostic Market (Billion US$), 2009 & 2010
Figure 5-14: Global - Forecast for Homeostasis Diagnostic Market (Billion US$), 2011-2013
Figure 5-15: Global - Hematology Market (Billion US$), 2009-2013
Figure 5-16: Global - Immunohematology Diagnostic Market (Billion US$), 2009-2013
Figure 6-1: Global - Diabetic Population (Million), 2010 & 2030
Figure 6-2: Global - Diabetes Diagnostic & Therapies Market (Billion US$), 2009-2013
Figure 6-3: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2009-2013
Figure 6-4: Global - Cancer In-Vitro Diagnostic Market (Billion US$), 2009-2013
Figure 6-5: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012
Figure 6-6: Global - Tuberculosis Diagnostic Market by Segment (%)
Figure 6-7: Global - Tuberculosis Detection and Monitoring Market by Segment (%)
Figure 6-8: Global - Influenza Diagnostic Market (Million US$), 2008-2013
Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2010
Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2013
Figure 7-3: US - In Vitro Diagnostic Market (Billion US$), 2008-2010
Figure 7-4: US - Labs in IVD Market by Type (%), 2008
Figure 7-5: US - Forecast for In Vitro Diagnostic Market (Billion US$), 2011-2013
Figure 7-6: Canada - In Vitro Diagnostic Market (Billion US$), 2009-2013
Figure 7-7: Europe - In Vitro Diagnostic Market (Billion Euro), 2008-2013
Figure 7-8: Europe - In Vitro Diagnostic Market by Country (%), 2009
Figure 7-9: Germany - In Vitro Diagnostic Market (Billion Euro), 2008-2010
Figure 7-10: Germany - In Vitro Diagnostic Market by Segment (%), 2009
Figure 7-11: Germany - Forecast for In Vitro Diagnostic Market (Billion Euro), 2011-2013
Figure 7-12: France - In Vitro Diagnostic Market (Billion Euro), 2008-2010
Figure 7-13: France - In Vitro Diagnostic Reagents Market by Segment (%)
Figure 7-14: France - Forecast for In Vitro Diagnostic Market (Billion Euro), 2011-2013
Figure 7-15: Italy - In Vitro Diagnostic Market (Billion Euro), 2008-2010
Figure 7-16: Italy - In Vitro Diagnostic Market by Segment (%), 2008
Figure 7-17: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2008
Figure 7-18: Italy - Forecast for In Vitro Diagnostic Market (Billion Euro), 2011-2013
Figure 7-19: UK - In Vitro Diagnostic Market (Billion Euro), 2008-2010
Figure 7-20: UK- In Vitro Diagnostic Market by Segment (%), 2009
Figure 7-21: UK - Forecast for In Vitro Diagnostic Market (Billion Euro), 2011-2013
Figure 7-22: Spain - In Vitro Diagnostic Market (Billion Euro), 2008-2013
Figure 7-23: Japan - In Vitro Diagnostic Market (Billion Yen), 2009 & 2010
Figure 7-24: Japan - In Vitro Diagnostic Market by Segment (%), 2009
Figure 7-25: Japan - Share of Players in In Vitro Diagnostic Market
Figure 7-26: Japan - Forecast for In Vitro Diagnostic Market (Billion Yen), 2011-2013
Figure 7-27: China - In Vitro Diagnostic Market (Billion US$), 2009 & 2010
Figure 7-28: China - In Vitro Diagnostic Market by Segment (%), 2009
Figure 7-29: China - Forecast for In Vitro Diagnostic Market (Billion US$), 2011-2013
Figure 7-30: India - In Vitro Diagnostic Market (Million US$), 2008-2010
Figure 7-31: India - In Vitro Diagnostic Market by Segment (%), 2009
Figure 7-32: India - Forecast for In Vitro Diagnostic Market (Million US$), 2011-2013
Figure 7-33: Turkey - In Vitro Diagnostic Market (Million Euro), 2008-2010
Figure 7-34: Turkey - Share of Clinical Laboratories by Type
Figure 7-35: Turkey - Forecast for In Vitro Diagnostic Market (Million Euro), 2011-2013
Figure 7-36: Brazil - In Vitro Diagnostic Market (Million US$), 2008-2010
Figure 7-37: Brazil - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-38: Brazil - Forecast for In Vitro Diagnostic Market (Million US$), 2011-2013
Figure 7-39: Mexico - In Vitro Diagnostic Market (Million US$), 2008-2010
Figure 7-40: Mexico - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-41: Mexico - Forecast for In Vitro Diagnostic Market (Million US$), 2011-2013
Figure 11-1: Global - R&D Expenditure on IVD in Comparison to Other Industrial Sectors (%)
Figure 12-1: Global - In Vitro Diagnostic Market by Player (%)
Figure 12-2: Roche Holding Ltd. - Diagnostic Division Revenues by Segment (%), 2009
Figure 12-3: Abbott Laboratories - Diagnostic Products Sales (Million US$), 2007-2009
Figure 12-4: Siemens AG - Diagnostic Division Revenues by Segment (%)
Figure 12-5: Beckman Coulter - Clinical Diagnostics Revenues by Segment (%), 2009
[Fade out list of tables / figures]